CNSP
CNS Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.73
−2.66%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-91.8%
Return on equity
-76.1%
Return on assets
-92.9%
Return on invested capital
0.00x
Asset turnover
-$13.4M
Cash from operations
$14
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026